Compare IDYA & TMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | TMC |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | Canada |
| Employees | N/A | 47 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2019 | N/A |
| Metric | IDYA | TMC |
|---|---|---|
| Price | $31.40 | $4.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | ★ $51.21 | $9.42 |
| AVG Volume (30 Days) | 824.6K | ★ 5.5M |
| Earning Date | 05-05-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,710,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $191.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $13.45 | $1.60 |
| 52 Week High | $39.28 | $11.35 |
| Indicator | IDYA | TMC |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 24.78 |
| Support Level | $29.15 | $3.96 |
| Resistance Level | $35.47 | $6.59 |
| Average True Range (ATR) | 1.47 | 0.38 |
| MACD | -0.26 | -0.16 |
| Stochastic Oscillator | 30.38 | 3.53 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.